Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

Faries, Douglas E.; Yalcin, Ilker; Harder, Donald; Heiligenstein, John H.

doi:10.1177/108705470100500204

Cited by 163 publications

(134 citation statements)

References 18 publications

Supporting

Mentioning

130

Contrasting

Unclassified

Order By: Relevance

“…The psychiatrist also completed the ADHD Rating Scale (ADHD-RS-IV), consisting of the 9 Inattentive and 9 Hyperactive-Impulsive DSM-IV symptoms of ADHD, each rated on the basis of the parent interview on a 4-point scale ranging from 0 (never or rarely) to 3 (very often) (DuPaul 1998;Faries et al 2001). The patient was also given a single rating, ranging from 1 (''normal=not ill'') to 7 (''among the most extremely ill patients'') on the National Institute of Mental Health (NIMH) Clinical Global Impressions (CGI) scale of severity (National Institute of Mental Health 1985).…”

Section: Weekly Assessments and Instrumentsmentioning

confidence: 99%

Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder

Solanto

Newcorn²,

Vail³

et al. 2009

Journal of Child and Adolescent Psychopharmacology

View full text Add to dashboard Cite

Objective: This study compared the methylphenidate (MPH) dose-response profiles of children with the Predominantly Inattentive (PI) and Combined (CB) subtypes of attention-deficit=hyperactivity disorder (ADHD). It is the first such study to enroll a sample comprised exclusively of children, all but one of whom had no prior exposure to ADHD medications. Method: The design was a double-blind crossover with 1-week exposures to placebo and low, medium, and high, fixed, three times daily (t.i.d.) dosage regimens of immediate-release MPH, administered in random order. Parents and teachers completed weekly behavioral questionnaires (Conners, Swanson, Kotkin, Agler, M-Flynn and Pelham Scale [SKAMP]) and a child psychiatrist provided weekly ratings of symptom severity (ADHD Rating Scale [ADHD-RS]), side effects (Side Effects Rating Scale), and a Clinical Global Impressions-Severity (CGI-S). In addition, laboratory measures of vigilance (Continuous Performance Test [CPT]) and resistance to cognitive interference (Stroop) were administered weekly. Results: Twenty-five children (15 CB, 10 PI), who met rigorous diagnostic criteria for their ADHD subtype, completed the study. Groups did not differ on demographic variables or severity at baseline. Behavioral questionnaires and clinical ratings indicated significant improvement on MPH for both subtypes but no differences in response profiles of the two groups. Drug effects were predominantly linear for both subtypes. Effects of MPH were significant for the CPT, but not the Stroop, instrument with no differences between ADHD subtypes. Conclusions: Results support the clinical utility of MPH in the treatment of the PI subtype and provide no evidence of differences in response between the subtypes.

show abstract

Section: Weekly Assessments and Instrumentsmentioning

confidence: 99%

Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder

Solanto

Newcorn²,

Vail³

et al. 2009

Journal of Child and Adolescent Psychopharmacology

View full text Add to dashboard Cite

show abstract

“…The scale has acceptable levels of inter-rater reliability, test-retest reliability, internal consistency, convergent validity, discriminant validity and responsiveness (10). The psychometric properties of the Farsi version of ADHD-RS-IV has been reported by Ghanizadeh previously (11).…”

Section: Adhd Rating Scale IV (Adhd-rs-iv)-home Versionmentioning

confidence: 64%

Concurrent Validity of the Behavior Rating Inventory of Executive Function in Children with Attention Deficit Hyperactivity Disorder

Zarrabi¹,

Shahrivar²,

Doost³

et al. 2015

Iran J Psychiatry Behav Sci

View full text Add to dashboard Cite

Background: Attention deficit hyperactivity disorder (ADHD) is a common psychiatric disorder in which impairment of executive functions plays an important role. Objectives: The main objective of this study was to assess the validity of the Behavior Rating Inventory of Executive Function (BRIEF) in children with ADHD. Patients and Methods: Thirty children, aged 7-12 years, attending the child and adolescent clinic of Roozbeh hospital and diagnosed with ADHD according to interview with a child and adolescent psychiatrist, formed our ADHD group. In contrast, thirty participants of the control group were selected from 7 to 12 year-old students according to Conners' Teacher/Parent Rating Scale and did not have ADHD. The kiddie schedule for affective disorders and schizophrenia-present and lifetime version-Persian version was also completed for all children to rule out other psychiatric disorders. After oral consent, parents of 60 children (ADHD = 30, control = 30), completed three questionnaires of ADHD-Rating Scale-IV, Conners' Parent Rating Scale-Revised: Short Version and BRIEF. Results: Children in ADHD group got higher scores than those in the control group in all subscales and indices of BRIEF (P < 0.001). There were also good correlations between subscales and indices of BRIEF and the two other rating scales (P < 0.001). Conclusion: BRIEF could be used as a valid tool to assess behavioral aspects of executive functions, especially to discriminate children with ADHD and normal ones.

show abstract

“…A szerzők vizsgálatai a mérőeszköz egy-és kétfaktoros struktúráját is kimutatták, a skála a gyermek-és serdülőkori ADHD érvényes mérőeszközé-nek tekinthető [32]. A kérdőív megbízhatóságát további vizsgálatok is alátámasztották [33,34].…”

Section: Figyelemhiányos Hiperaktivitás-zavar (Adhd) Skála (Attentionunclassified

A dohányzás és az alkoholfogyasztás együttes előfordulásának összefüggései a figyelemhiányos hiperaktivitás-zavar tüneteivel kilencedik osztályos tanulók körében

Matuszka

Bácskai²,

Czobor

et al. 2015

Orvosi Hetilap

View full text Add to dashboard Cite

Bevezetés: A fi gyelemhiányos hiperaktivitás-betegség korábbi vizsgálatok eredményei alapján összefüggésben áll a serdülőkori dohányzással és alkoholfogyasztással, azok kockázati tényezőjének tekinthető. Mivel a felnőttkorban kialakuló szenvedélybetegségek erős prediktora a fi gyelemhiányos hiperaktivitás-betegség, valamint a serdülőkori dohányzás és alkoholfogyasztás is, a később kialakuló addiktív problémák megelőzése szempontjából fontos a serdülő-kori összefüggések vizsgálata. Célkitűzés: A fi gyelemhiányos hiperaktivitás-betegség tüneteinek és az együttesen előforduló dohányzás és alkoholhasználat összefüggéseinek feltárása 9. osztályos serdülők körében. Módszer: A budapesti állami fenntartású középiskolák 9. osztályába járó fi atalok körében 944 elemű reprezentatív mintán általánosí-tott lineáris kevert modell elemzéseket és logisztikusregresszió-elemzéseket végeztek. Eredmények: A jelenlegi dohányzás prevalenciája 29,6%, a jelenlegi alkoholfogyasztásé 41,4%, míg a két szer együttes használatáé 21,7% volt. Az alkoholfogyasztás és a dohányzás szignifi káns pozitív összefüggést mutatott a Figyelemhiányos-Hiperaktivitás Zavar Skála pontszámaival, valamint a Figyelemzavar és a Hiperaktivitás/Impulzivitás Alskála pontszámaival. Következteté-sek: Az eredmények felhívják a fi gyelmet a fi gyelemhiányos hiperaktivitás-betegség tüneteinek szerepére az alkoholfogyasztás és dohányzás kialakulása szempontjából veszélyeztetett serdülők körében. Orv. Hetil., 2015, 156(43), 1750-1757. Kulcsszavak: fi gyelemhiányos-hiperaktivitás zavar, alkohol, dohányzás, együttes használat, serdülőkAssociations between concurrent use of tobacco and alcohol and symptoms of attention-defi cit hyperactivity disorder among ninth grader students Introduction: Attention-defi cit hyperactivity disorder is a risk factor of smoking and alcohol drinking in adolescence. Since attention-defi cit hyperactivity disorder and smoking and alcohol drinking in adolescence are predictors for the development of substance use disorders in adulthood, it is important to understand the nature of these associations. Aim: The aim of the authors was to investigate associations between attention-defi cit hyperactivity disorder symptoms and the joint use of alcohol and nicotine among 9th graders. Method: A representative sample of 944 pupils attending state-run secondary schools in Budapest were recruited. Generalized Linear Mixed Model and logistic regression analyses have been conducted. Results: The prevalence was 29.6% and 41.4% for current smoking and current alcohol drinking, respectively. The prevalence of their concurrent-use was 21.7%. Alcohol drinking and smoking showed a signifi cant positive association with the total scores of Attention-Defi cit Hyperactivity Disorder Scale and with the Attention Defi cit and Hyperactivity/Impulsivity subscales. Conclusions: The fi ndings highlight the potential importance of attention-defi cit hyperactivity disorder in the development of the joint use of these substances.

show abstract

Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

Cited by 163 publications

References 18 publications

Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder

Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder

Concurrent Validity of the Behavior Rating Inventory of Executive Function in Children with Attention Deficit Hyperactivity Disorder

A dohányzás és az alkoholfogyasztás együttes előfordulásának összefüggései a figyelemhiányos hiperaktivitás-zavar tüneteivel kilencedik osztályos tanulók körében

Contact Info

Product

Resources

About